Tapinarof for Cutaneous Lupus Erythematosus

EARLY_PHASE1Enrolling by invitationINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 3, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Cutaneous Lupus Erythematosus

Interventions

DRUG

Tapinarof

A thin layer of tapinarof cream is applied to affected areas once daily.

Trial Locations (1)

Northwestern University Department of Dermatology, Chicago

All Listed Sponsors

lead

Northwestern University

OTHER

NCT06661213 - Tapinarof for Cutaneous Lupus Erythematosus | Biotech Hunter | Biotech Hunter